Bluejay Diagnostics, Inc.

Nasdaq:BJDX

Surgical & Medical Instruments & Apparatus·ACTON, MA

CEO

Dey Indranil

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/6/26	→
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K/A	FY 2024	12/31/24	4/29/25	→
10-K	FY 2024	12/31/24	3/31/25	→
↓

Earnings Releases (8-K)

10 shown

Filed	Period
3/6/26	Q1 FY2026	→
11/9/23	Q4 FY2023	→
8/16/23	Q3 FY2023	→
5/10/23	Q2 FY2023	→
3/20/23	Q1 FY2023	→
11/8/22	Q4 FY2022	→
↓

News (8-K)

44 shown

Filed	Type	Description
2/20/26	Reg FD	Regulation FD Disclosure	→
2/18/26	Reg FD	Regulation FD Disclosure	→
1/30/26	Vote	Material Modification to Rights of Security Holders	→
12/30/25	Reg FD	Regulation FD Disclosure	→
11/10/25	Reg FD	Regulation FD Disclosure	→
10/14/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

20 shown

Filed	Form	Description
11/26/25	424B3	424B3	→
10/23/25	S-3	REGISTRATION STATEMENT	→
5/8/25	424B3	424B3	→
4/29/25	S-3	REGISTRATION STATEMENT	→
6/28/24	424B1	424B1	→
6/24/24	S-1/A	AMENDMENT NO. 1 TO FORM S-1	→
↓

Filing History(201 filings)

TypeDateAccessionPeriodSize

10-K

Mar 6, 2026

0001213900-26-024616ANNUAL REPORT

Dec 31, 2025

5.6 MB

8-K

Mar 6, 2026

0001213900-26-024352FORM 8-K

Mar 6, 2026

252.3 KB

8-K

Feb 20, 2026

0001213900-26-018638CURRENT REPORT

Feb 20, 2026

246.6 KB

SCHEDULE 13G

Feb 18, 2026

0001172661-26-001307

—

10.2 KB

8-K

Feb 18, 2026

0001213900-26-017641CURRENT REPORT

Feb 17, 2026

219.8 KB

SCHEDULE 13G

Feb 17, 2026

0001172661-26-001270

—

10.2 KB

SCHEDULE 13G/A

Feb 13, 2026

0001213900-26-016486

—

11.9 KB

SCHEDULE 13G

Feb 5, 2026

0001213900-26-012963

—

8.7 KB

SCHEDULE 13G

Feb 5, 2026

0001213900-26-012962

—

8.4 KB

8-K

Jan 30, 2026

0001213900-26-009792CURRENT REPORT

Jan 27, 2026

250.9 KB

8-K

Dec 30, 2025

0001213900-25-126358CURRENT REPORT

Dec 29, 2025

213.8 KB

EFFECT

Nov 26, 2025

9999999995-25-003400

—

1.7 KB

424B3

Nov 26, 2025

0001213900-25-115615PROSPECTUS

—

168.1 KB

8-K

Nov 10, 2025

0001213900-25-108192CURRENT REPORT

Nov 10, 2025

250.6 KB

10-Q

Nov 7, 2025

0001213900-25-107599QUARTERLY REPORT

Sep 30, 2025

5.6 MB

S-3

Oct 23, 2025

0001213900-25-101729REGISTRATION STATEMENT

—

431.7 KB

SCHEDULE 13G

Oct 16, 2025

0001213900-25-099605

—

17.0 KB

8-K

Oct 14, 2025

0001213900-25-098281CURRENT REPORT

Oct 9, 2025

1.0 MB

8-K

Oct 9, 2025

0001213900-25-097564CURRENT REPORT

Oct 3, 2025

29.9 MB

8-K

Aug 15, 2025

0001213900-25-077600CURRENT REPORT

Aug 15, 2025

219.8 KB

8-K

Aug 11, 2025

0001213900-25-073870CURRENT REPORT

Aug 7, 2025

252.4 KB

10-Q

Aug 7, 2025

0001213900-25-073064QUARTERLY REPORT

Jun 30, 2025

4.2 MB

8-K

Jul 28, 2025

0001213900-25-068296CURRENT REPORT

Jul 23, 2025

246.2 KB

8-K

Jun 20, 2025

0001213900-25-055724CURRENT REPORT

Jun 18, 2025

201.2 KB

DEFA14A

Jun 4, 2025

0001213900-25-050915DEFINITIVE ADDITIONAL MATERIALS

—

90.6 KB

25 filings shown

Filed	Form	Description
11/14/24	SC 13G	SC 13G	→
11/14/24	SC 13G/A	SC 13G/A	→
7/3/24	SC 13G	SCHEDULE 13G	→
2/14/24	SC 13G	SC 13G	→
1/3/24	SC 13G	BJDX 13G 1.03.24	→
12/14/23	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓

Bluejay Diagnostics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(201 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/4/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
5/16/25	DEF 14A	DEF 14A	→
5/6/25	PRE 14A	PRE 14A	→
10/16/24	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
9/10/24	DEF 14A	DEF 14A	→
8/30/24	PRE 14A	PRE 14A	→
↓